Rohit K Katial, MD - National Jewish Health Main Campus

Donald Y M Leung, PhD, is an allergist and immunologist at National Jewish Health. Dr. Leung serves as Division Head of Pediatric Allergy and Clinical Immunology. Research Interests: My research focuses on mechanisms by which bacteria and viruses contribute to skin inflammation of atopic dermatitis and psoriasis. I am interested in why patients with atopic dermatitis are prone to microbial infection. As well, I have an interest in mechanisms resulting steroid resistance and the treatment of peanut allergy.

Rafeul Alam, MD, is an allergist and immunologist at National Jewish Health. Dr. Alam serves as Chief of the Division of Allergy and Clinical Immunology. Special Interests: Basic Science Research: The major research interest of the laboratory is signal transduction mechanism of eosinophils and T cells, and signaling mechanism of asthma. Translational/Clinical Research: The major interests are the signaling abnormalities of asthma and airway allergic diseases.

Jessica Galant-Swafford, MD, is an allergist and immunologist at National Jewish Health. Dr. Galant-Swafford is in the Division of Allergy and Clinical Immunology. Dr. Galant-Swafford cares for patients with allergic diseases, asthma, and complex immune system disorders. She utilizes the latest clinical tools to help diagnose and treat patients with immunodeficiency and immune dysregulation. Her research focuses on the inflammatory and autoimmune complications of primary immunodeficiency including chronic lung and gastrointestinal disease. She specializes in the care of patients with common variable immunodeficiency (CVID) and patients with secondary immunodeficiencies such as those caused by cancer and immunosuppressive therapy. By studying the interplay of human genetics and the microbiome, she hopes to predict complications and personalize therapies for these conditions. As Clinical Director of the new Immunodeficiency-Immune Dysregulation Program at National Jewish Health, Dr. Galant-Swafford will be developing a coordinated, interdisciplinary approach to improving the quality of life for complex immunology patients.